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Introduction
Cardiotoxicity has been associated with various types of chemotherapeutic
drugs contributing to a plethora of cardiac insults and is a significant side effect
when treating cancer. Many highly effective anticancer drugs are severely dose
dependent, and at higher doses can lead to: cardiac arrhythmias, hypertension,
and lethal cardiomyopathy. A well known example of this cardiotoxic side effect
is Doxorubicin, a common chemotherapeutic used to treat cancers of the breast,
ovary, bladder, and thyroid. Extensive research has shown that high doses of
doxorubicin detrimentally alters the normal function of cardiac fibroblasts and
cardiomyocytes. In contrast to the extensive research on the toxic effects of
chemotherapeutics like doxorubicin in cardiomyocytes, little is known on the
effects in cardiac fibroblasts and mechanisms of these drugs on the cardiac
extracellular matrix (cECM). We show that doxorubicin has a direct impact on
cardiac fibroblasts and in turn the function of the cECM, indicating that the
cECM plays an important role in cardiac toxicity induced by doxorubicin.

Doxorubicin
• DOX is a member of a family of
highly effective chemotherapeutic
drugs called anthracyclines
• Anthracyclines are isolated from
the bacterial source Streptomyces
peucetius var. caesius
• DOX has three mechanisms of
cytotoxicity, which also affect
non-cancerous cells:
• Inhibition of topoisomerase II
• Production of reactive oxygen
species
• DNA intercalation

ECM Staining
CFBs grown in 6-well plates were exposed to 1μM DOX for 24-hours.
Culture media were then replaced with media free of DOX. After five
days, CFBs were stained with Alcian blue for glycoproteins and
picrosirius red for collagens.

Alcian blue staining of CFB control (left)
and DOX-treated (right)

Picrosirius red staining of CFB control (left)
and DOX-treated (right)

Duplex TMT Assay
1μM DOX, 24 hr
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Fold of Change

Endothelial protein C receptor

2.98↑

Isoform 2 of Intercellular adhesion molecule 1

2.46↑

Aldehyde dehydrogenase family 1 member A3

2.43↑

Arachidonate 5-lipoxygenase

1.96 ↑

L-lactate dehydrogenase B chain

1.95↑

BLOC-1-related complex subunit 7

1.85↑

Protein NDRG1

1.83↑

Serine protease inhibitor A3G

1.81↑

Antizyme inhibitor 1

1.80↑

Syndecan-4

2.52↓

Denticleless protein homolog

2.42↓

Profilin-3

1.98↓

Myb-binding protein 1A

1.97↓

Potassium voltage-gated channel subfamily E member 4

1.90↓

Thrombospondin-1

1.89↓

Transmembrane

1.83↓

Ribosomal L1 domain-containing protein 1

1.81↓

Thrombospondin-2

1.81↓

Quantitative PCR Analysis
TMT-127

Cytotoxicity Test

Combine labelled peptides

• Primary cardiac fibroblasts (CFBs) isolated from BALB/c mice
were exposed to various concentrations of DOX for 24 hours.
• Resazurin was added three hours prior to the measurement.
• 1 μM DOX yielded the cell viability of 70-80%. This concentration
was used in all the subsequent experiments.

High pH reverse phase fractionation
Low pH reverse phase LC

Expression of Extracellular Matrix
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Future Work
Future aim is to examine the direct intercellular signaling between doxorubicin treated
fibroblasts and cardiac myocytes. Primary cardiac fibroblasts and cardiomyocytes
isolated from BALB/c mice
• Co-culture of Dox treated with fibroblasts and cardiomyocytes
• Endpoints
• Global gene expression changes in myocytes: RNA-seq
• Cardiomyocyte functional assay: Fluorescent imaging using calcium
indicator
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Acknowledgements

Protein identification and quantification

We acknowledge support from the Institutional Development Awards (IDeA) from the
National Institute of General Medical Sciences of the National Institutes of Health under
Grants #P20GM103408, P20GM109095, and 1C06RR020533. We also acknowledge support
from The Biomolecular Research Center at Boise State, BSU-Biomolecular Research Center,
RRID:SCR_019174, with funding from the National Science Foundation, Grants #0619793 and
#0923535; the M. J. Murdock Charitable Trust; Lori and Duane Stueckle, and the Idaho State
Board of Education. We would especially like to acknowledge the support from the Higher
Education Research Fellowship Program (HERC)

Differentially expressed protein list

The cytotoxicity assay (left) was carried out in a 96-well plate
with concentrations of DOX ranging from high to low. The pink
wells have higher cell viability. 1 μM of DOX yielded 70-80% and
IC50 was approximately 25 μM.

Differentially expressed protein list

• Velos Pro Dual-Pressure Linear Ion Trap Mass Spectrometer
(Thermo Fisher Scientific)
• C18 reverse phase nano column: 0.075 x 100 mm, 3μm, 120Å
• HCD fragmentation with 45% normalized collision energy
• Proteome Discover 2.2 (Thermo Fisher Scientific)
• Sequest HT search engine
• Sequence database: UniProtKB/Swiss-Prot protein database
for mouse (obtained on December 10, 2018)

